Categories Uncategorized

Study Suggests Psychedelics May Encourage Connectedness, Reduce Narcissism

In a new study published in “Psychopharmacology,”, researchers argue that feelings of awe elicited from psychedelic drugs may influence narcissistic personality traits positively. The study discovered that psychedelic experiences that evoke feelings of awe were connected to increased feelings of empathy and connectedness, which are linked to reduced levels of exploitative-entitled narcissism.

Because prior research had demonstrated that psychedelic substances could improve mental well-being and intensify feelings of social connectedness, the researchers of this study chose to instead focus on finding out whether the effects from these substances had an impact on narcissism.

The study authors, Ruairi Patterson, a University of Surrey PhD student, and Valerie van Mulukom, a research fellow at Coventry University, stated that they had gone through previous research findings that demonstrated psychedelic drug use to help boost empathy levels. Because lower empathy levels were linked to narcissism, particularly maladaptive narcissism, the two were interested in finding out if there was a link between maladaptive narcissism levels and the use of psychedelics.

However, because prior research focused more on depression and less on narcissistic personality disorder, the authors decided to set their course in that direction. They did this by investigating the connection between narcissistic personality traits and psychedelic drug experiences.

Through the use of Qualtrics, an online survey platform, the researchers surveyed 414 people who had experience with serotonergic psychedelic drugs, such as mushrooms that contained psilocybin and LSD. Apart from answering questions about their most emotionally intense, significant, impressive or awe-inspiring psychedelic experience of the past five years, the participants also completed assessments of narcissism, empathy and connectedness to others.

Strangely enough, ego death was found to be independent of narcissism levels. The researchers discovered that the more awe an individual experienced during a psychedelic experience, the lower the levels of maladaptive narcissism through increased empathetic drive and feelings of connectedness.

Additionally, they also found out that individuals who had a highly significant experience when on psychedelic drugs had a lower score on maladaptive narcissism. This is especially true if they experience significant feelings of awe during the psychedelic trip. Recently experienced awe-inducing occurrences also resulted in stronger connections to humanity and nature in addition to a higher motivation to take part in emotional empathy.

However, as the study only collected data at one point in time, the data was correlational, meaning that it could not be used to determine causal relationships between narcissism, empathy, awe experiences and psychedelics use.

Rritual Mushrooms Inc. is a company you should watch in the psychedelics sector. It was created to help people include superfoods, adaptogens and functional mushrooms in their diets in order to meet the challenges of life today.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage

The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…

4 days ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…

1 week ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…

4 weeks ago

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…

4 weeks ago